Mehmet Serdar Kucukoglu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mehmet Serdar Kucukoglu has a total of 120 co-authors. Here are the top co-authors by number of shared publications:
- Umit Yasar Sinan
Department of Cardiology, Istanbul University-Cerrahpasa, Institute of Cardiology, Istanbul, Turkiye
9 shared publications Rengin Demir
Department of Cardiology, Cardiology Institute, Istanbul University-Cerrahpasa, Haseki St., 34096, Istanbul, Turkey
4 shared publications- Ayşen Ağaçdiken Ağır
Department of Cardiology, Faculty of Medicine, Kocaeli University, Kocaeli, Türkiye
3 shared publications - Dilek Ural
Department of Cardiology, Faculty of Medicine, Koç University, İstanbul, Türkiye
3 shared publications - Ece Yurtseven
Department of Cardiology, Faculty of Medicine, Koç University, İstanbul, Türkiye
3 shared publications - Ersan Atahan
Department of Chest Diseases, Istanbul University-Cerrahpasa Cerrahpasa Faculty of Medicine, Istanbul, Turkey
3 shared publications
Latest Publications
- Open Access
- 16 June 2026
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 56 (3) , 794-800
Reliability and validity of the Turkish version of the Barthel Index-dyspnea in patients with pulmonary hypertension
Background/aim: The Barthel Index-dyspnea (BI-d) is a respiratory disease-specific tool developed on the basis of the Barthel Index (BI), which provides a simple and quick way to measure the degree of dyspnea in activities of daily living (ADL). Dyspnea is one of the most common symptoms of pulmonary hypertension (PH). The objective of this study was to explore the reliability and validity of the Turkish version of the BI-d in patients with PH. Materials and methods: A total of 73 PH patients were included in the study. Criterion validity was explored using the modified Medical Research Council (mMRC) dyspnea scale, 6-min walk test (6MWT), and London Chest Activities of Daily Living (LCADL) scale, while divergent validity was examined through correlations between the BI-d and BI. Results: The BI-d demonstrated strong correlations with the LCADL (r = 0.801) and mMRC (r = 0.775), and a moderately negative correlation with the 6MWD (r = –0.510), supporting criterion-related validity. A weak negative correlation with the BI (r = –0.289) supported divergent validity. The BI-d scores differed significantly across the mMRC grades and PH functional classes, confirming known-group validity. Reliability analyses showed good internal consistency (Cronbach’s α = 0.85) and excellent test–retest reliability (intraclass correlation coefficient = 0.94). Conclusion: The Turkish version of the BI-d demonstrates high reliability and validity in PH. As a tool that integrates respiratory burden with activity-related functional performance, it provides a practical assessment of dyspnea-related impairment during ADL.
- 16 June 2026
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 56 (3) , 794-800
Open AccessReliability and validity of the Turkish version of the Barthel Index-dyspnea in patients with pulmonary hypertension
Background/aim: The Barthel Index-dyspnea (BI-d) is a respiratory disease-specific tool developed on the basis of the Barthel Index (BI), which provides a simple and quick way to measure the degree of dyspnea in activities of daily living (ADL). Dyspnea is one of the most common symptoms of pulmonary hypertension (PH). The objective of this study was to explore the reliability and validity of the Turkish version of the BI-d in patients with PH. Materials and methods: A total of 73 PH patients were included in the study. Criterion validity was explored using the modified Medical Research Council (mMRC) dyspnea scale, 6-min walk test (6MWT), and London Chest Activities of Daily Living (LCADL) scale, while divergent validity was examined through correlations between the BI-d and BI. Results: The BI-d demonstrated strong correlations with the LCADL (r = 0.801) and mMRC (r = 0.775), and a moderately negative correlation with the 6MWD (r = –0.510), supporting criterion-related validity. A weak negative correlation with the BI (r = –0.289) supported divergent validity. The BI-d scores differed significantly across the mMRC grades and PH functional classes, confirming known-group validity. Reliability analyses showed good internal consistency (Cronbach’s α = 0.85) and excellent test–retest reliability (intraclass correlation coefficient = 0.94). Conclusion: The Turkish version of the BI-d demonstrates high reliability and validity in PH. As a tool that integrates respiratory burden with activity-related functional performance, it provides a practical assessment of dyspnea-related impairment during ADL.
- Open Access
- 22 July 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (15) , 5188
Effect of Iron Deficiency on Right Ventricular Strain in Patients Diagnosed with Acute Heart Failure
Background: Iron deficiency (ID) is a prevalent comorbidity of heart failure (HF), affecting up to 59% of patients, regardless of the presence of anaemia. Although its negative impact on left ventricular (LV) function is well documented, its effect on right ventricular (RV) function remains unclear. This study assessed the effects of ID on RV global longitudinal strain (RV-GLS) in patients diagnosed with acute decompensated HF (ADHF). Methods: This study included data from 100 patients hospitalised with ADHF irrespective of LV ejection fraction (LVEF) value. ID was defined according to the European Society of Cardiology HF guidelines as serum ferritin p = 0.05) and RV free wall GLS (−14.7% vs. −18.2%; p = 0.005) were significantly lower in patients with ID, indicating subclinical RV systolic dysfunction. Conclusions: ID was associated with subclinical impairment of RV systolic function in patients diagnosed with ADHF, as evidenced by reductions in TAPSE and RV-GLS, despite the preservation of conventional RV systolic function parameters. Further research validating these findings and exploring the underlying mechanisms is warranted.
- 22 July 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (15) , 5188
Open AccessEffect of Iron Deficiency on Right Ventricular Strain in Patients Diagnosed with Acute Heart Failure
Background: Iron deficiency (ID) is a prevalent comorbidity of heart failure (HF), affecting up to 59% of patients, regardless of the presence of anaemia. Although its negative impact on left ventricular (LV) function is well documented, its effect on right ventricular (RV) function remains unclear. This study assessed the effects of ID on RV global longitudinal strain (RV-GLS) in patients diagnosed with acute decompensated HF (ADHF). Methods: This study included data from 100 patients hospitalised with ADHF irrespective of LV ejection fraction (LVEF) value. ID was defined according to the European Society of Cardiology HF guidelines as serum ferritin p = 0.05) and RV free wall GLS (−14.7% vs. −18.2%; p = 0.005) were significantly lower in patients with ID, indicating subclinical RV systolic dysfunction. Conclusions: ID was associated with subclinical impairment of RV systolic function in patients diagnosed with ADHF, as evidenced by reductions in TAPSE and RV-GLS, despite the preservation of conventional RV systolic function parameters. Further research validating these findings and exploring the underlying mechanisms is warranted.
- Open Access
- 23 June 2025
- Published by MDPI AG in Preprints.org
Effect of Iron Deficiency on Right Ventricular Strain in Patients Diagnosed with Acute Heart Failure
Background: Iron deficiency (ID) is a prevalent comorbidity of heart failure (HF), affecting up to 59% of patients, regardless of the presence of anaemia. Although its negative impact on left ventricular (LV) function is well documented, its effect on right ventricular (RV) function remains unclear. This study assessed the effects of ID on RV global longitudinal strain (RV-GLS) in patients diagnosed with acute decompensated HF (ADHF). Methods: This study included data from 100 patients hospitalised with ADHF irrespective of LV ejection fraction (LVEF) value. ID was defined according to the European Society of Cardiology HF guidelines as serum ferritin <100 ng/mL or ferritin 100–299 ng/mL, with transferrin saturation <20%. Anaemia was defined according to World Health Organization criteria as haemoglobin level <12 g/dL in women and <13 g/dL in men. RV systolic function was assessed using parameters including RV ejection fraction (RVEF), tricuspid annular plane systolic excursion (TAPSE), RV fractional area change (FAC), peak systolic tissue Doppler velocity of the RV annulus (RV TDI S′), acceleration time of the RV outflow tract, and RV free wall GLS. Results: The mean (± SD) age of the study population (64% male) was 70 ± 10 years. The median LVEF was 35%, with 66% of patients classified with HF with reduced ejection fraction, 6% with HF with mid-range ejection fraction, and 28% with HF with preserved ejection fraction. Fifty-eight percent of patients had ID. There were no significant differences between patients with and without ID regarding demographics, LVEF, RV FAC, RV TDI S′, or systolic pulmonary artery pressure. However, TAPSE (15.6 versus [vs.] 17.2 mm; p=0.05) and RV free wall GLS (-14.7% vs. -18.2%; p=0.005) were significantly lower in patients with ID, indicating subclinical RV systolic dysfunction. Conclusion: ID was associated with subclinical impairment of RV systolic function in patients diagnosed with ADHF, as evidenced by reductions in TAPSE and RV-GLS, despite the preservation of conventional RV systolic function parameters. Further research validating these findings and exploring the underlying mechanisms is warranted.
- 23 June 2025
- Published by MDPI AG in Preprints.org
Open AccessEffect of Iron Deficiency on Right Ventricular Strain in Patients Diagnosed with Acute Heart Failure
Background: Iron deficiency (ID) is a prevalent comorbidity of heart failure (HF), affecting up to 59% of patients, regardless of the presence of anaemia. Although its negative impact on left ventricular (LV) function is well documented, its effect on right ventricular (RV) function remains unclear. This study assessed the effects of ID on RV global longitudinal strain (RV-GLS) in patients diagnosed with acute decompensated HF (ADHF). Methods: This study included data from 100 patients hospitalised with ADHF irrespective of LV ejection fraction (LVEF) value. ID was defined according to the European Society of Cardiology HF guidelines as serum ferritin <100 ng/mL or ferritin 100–299 ng/mL, with transferrin saturation <20%. Anaemia was defined according to World Health Organization criteria as haemoglobin level <12 g/dL in women and <13 g/dL in men. RV systolic function was assessed using parameters including RV ejection fraction (RVEF), tricuspid annular plane systolic excursion (TAPSE), RV fractional area change (FAC), peak systolic tissue Doppler velocity of the RV annulus (RV TDI S′), acceleration time of the RV outflow tract, and RV free wall GLS. Results: The mean (± SD) age of the study population (64% male) was 70 ± 10 years. The median LVEF was 35%, with 66% of patients classified with HF with reduced ejection fraction, 6% with HF with mid-range ejection fraction, and 28% with HF with preserved ejection fraction. Fifty-eight percent of patients had ID. There were no significant differences between patients with and without ID regarding demographics, LVEF, RV FAC, RV TDI S′, or systolic pulmonary artery pressure. However, TAPSE (15.6 versus [vs.] 17.2 mm; p=0.05) and RV free wall GLS (-14.7% vs. -18.2%; p=0.005) were significantly lower in patients with ID, indicating subclinical RV systolic dysfunction. Conclusion: ID was associated with subclinical impairment of RV systolic function in patients diagnosed with ADHF, as evidenced by reductions in TAPSE and RV-GLS, despite the preservation of conventional RV systolic function parameters. Further research validating these findings and exploring the underlying mechanisms is warranted.
- Open Access
Comorbidity Burden in Chronic Thromboembolic Pulmonary Hypertension: Implications and Outcome
Background and Objectives: Comorbidities, the coexistence of additional conditions with a primary disease, are increasingly prevalent, complicating disease management and clinical outcomes. While CTEPH is a well-studied condition in terms of risk factors and outcomes, the specific impact of comorbidity burden on clinical presentation, treatment decisions, and survival remains insufficiently explored. This study aims to assess the prevalence and burden of comorbidities in CTEPH and to examine their associations with initial clinical characteristics, treatment allocation, and survival, stratified by pulmonary endarterectomy (PEA) status. Materials and Methods: We included 187 CTEPH patients from eight tertiary PH centers (2009–2020). Cardiovascular and non-cardiovascular comorbidities were identified and categorized as 0, 1–2, or ≥3. Their impact on baseline six-minute walk distance (6MWD), hemodynamic parameters, operability decision, and survival was assessed. Results: Comorbidities were prevalent (90%), with 49% of patients having three or more. Hypertension, diabetes, coronary artery disease, and chronic kidney disease (CKD) were associated with lower 6MWD. Hypertension, atrial fibrillation, left heart failure, and CKD were linked to elevated right atrial and pulmonary arterial wedge pressures. Comorbidities rendered 39% of anatomically operable patients ineligible for surgery. No single comorbidity predicted survival. Among PEA patients, those with ≥3 cardiovascular comorbidities had worse survival (p = 0.010). In contrast, the comorbidity burden did not impact survival in non-PEA patients. PEA surgery (HR 0.342, 95% CI 0.130–0.899, p = 0.030) and baseline 6MWD (HR 0.997, 95% CI 0.994–1.000, p = 0.036) were identified as independent predictors of mortality. Conclusions: A high comorbidity burden is common in CTEPH and influences functional status, hemodynamics, and operability decisions. It may worsen long-term outcomes after PEA but appears to be less prognostic in non-operated patients, where disease severity seems to be the primary determinant of outcomes. These findings underscore the importance of careful operability assessment and proactive comorbidity management.
Open AccessComorbidity Burden in Chronic Thromboembolic Pulmonary Hypertension: Implications and Outcome
Background and Objectives: Comorbidities, the coexistence of additional conditions with a primary disease, are increasingly prevalent, complicating disease management and clinical outcomes. While CTEPH is a well-studied condition in terms of risk factors and outcomes, the specific impact of comorbidity burden on clinical presentation, treatment decisions, and survival remains insufficiently explored. This study aims to assess the prevalence and burden of comorbidities in CTEPH and to examine their associations with initial clinical characteristics, treatment allocation, and survival, stratified by pulmonary endarterectomy (PEA) status. Materials and Methods: We included 187 CTEPH patients from eight tertiary PH centers (2009–2020). Cardiovascular and non-cardiovascular comorbidities were identified and categorized as 0, 1–2, or ≥3. Their impact on baseline six-minute walk distance (6MWD), hemodynamic parameters, operability decision, and survival was assessed. Results: Comorbidities were prevalent (90%), with 49% of patients having three or more. Hypertension, diabetes, coronary artery disease, and chronic kidney disease (CKD) were associated with lower 6MWD. Hypertension, atrial fibrillation, left heart failure, and CKD were linked to elevated right atrial and pulmonary arterial wedge pressures. Comorbidities rendered 39% of anatomically operable patients ineligible for surgery. No single comorbidity predicted survival. Among PEA patients, those with ≥3 cardiovascular comorbidities had worse survival (p = 0.010). In contrast, the comorbidity burden did not impact survival in non-PEA patients. PEA surgery (HR 0.342, 95% CI 0.130–0.899, p = 0.030) and baseline 6MWD (HR 0.997, 95% CI 0.994–1.000, p = 0.036) were identified as independent predictors of mortality. Conclusions: A high comorbidity burden is common in CTEPH and influences functional status, hemodynamics, and operability decisions. It may worsen long-term outcomes after PEA but appears to be less prognostic in non-operated patients, where disease severity seems to be the primary determinant of outcomes. These findings underscore the importance of careful operability assessment and proactive comorbidity management.
- Open Access
- 4 April 2025
- Published by Springer Nature in Pediatric Cardiology
- Vol. 47 (2) , 821-829
The Role of Genetics in Congenital Heart Disease-Associated Pulmonary Arterial Hypertension
Pulmonary arterial hypertension associated with congenital heart disease (APAH-CHD) is a severely progressive condition with complex pathogenesis. The aim of this study was to evaluate the contribution of genetic variants to the development of PAH in patients with APAH-CHD. Fifteen children and twenty-seven adults diagnosed with APAH-CHD were enrolled. Targeted next-generation sequencing was performed on PAH-associated genes ( ABCC8 , ACVRL1 , AQP1 , ATP13A3 , BMPR2 , CAV1 , GDF2 , GGCX , EIF2AK4 , ENG , KCNK3 , KDR , KLK1 , SMAD1 , SMAD4 , SMAD9 , SOX17 , TBX4 , TET2 ). A total of 21 distinct variants across 11 different genes were detected in 17 of the 42 patients. ( ABCC8 = 2, ACVRL1 = 1, ATP13A3 = 2, BMPR2 = 4, GGCX = 1, EIF2AK4 = 2, ENG = 1, KDR = 3, SMAD1 = 1, SMAD9 = 1, TET2 = 3). Five of the patients with the mutation were under the age of 18, and 12 patients were adults. The most common CHD in patients with detected variants was VSD. PAH-related genetic variants were not uncommon in APAH-CHD patients. Our study identified 12 novel variants that may help to understand the genetic basis of APAH-CHD. Trial Registration The study has been registered on ClinicalTrials.gov with the identification number NCT05550389.
- 4 April 2025
- Published by Springer Nature in Pediatric Cardiology
- Vol. 47 (2) , 821-829
Open AccessThe Role of Genetics in Congenital Heart Disease-Associated Pulmonary Arterial Hypertension
Pulmonary arterial hypertension associated with congenital heart disease (APAH-CHD) is a severely progressive condition with complex pathogenesis. The aim of this study was to evaluate the contribution of genetic variants to the development of PAH in patients with APAH-CHD. Fifteen children and twenty-seven adults diagnosed with APAH-CHD were enrolled. Targeted next-generation sequencing was performed on PAH-associated genes ( ABCC8 , ACVRL1 , AQP1 , ATP13A3 , BMPR2 , CAV1 , GDF2 , GGCX , EIF2AK4 , ENG , KCNK3 , KDR , KLK1 , SMAD1 , SMAD4 , SMAD9 , SOX17 , TBX4 , TET2 ). A total of 21 distinct variants across 11 different genes were detected in 17 of the 42 patients. ( ABCC8 = 2, ACVRL1 = 1, ATP13A3 = 2, BMPR2 = 4, GGCX = 1, EIF2AK4 = 2, ENG = 1, KDR = 3, SMAD1 = 1, SMAD9 = 1, TET2 = 3). Five of the patients with the mutation were under the age of 18, and 12 patients were adults. The most common CHD in patients with detected variants was VSD. PAH-related genetic variants were not uncommon in APAH-CHD patients. Our study identified 12 novel variants that may help to understand the genetic basis of APAH-CHD. Trial Registration The study has been registered on ClinicalTrials.gov with the identification number NCT05550389.
- Open Access
- 1 January 2025
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 30 (4) , 276
Reply to Letter to the Editor: “Methodological Considerations in Non-Sustained Atrial Fibrillation and Stroke Risk”
The Anatolian Journal of Cardiology - Peer-reviewed cardiology journal publishing original research, reviews, case reports. Impact Factor 1.5. The Anatolian Journal of Cardiology - Leading international cardiology journal with Impact Factor 1.5. Publishing original research, reviews, and case reports in cardiovascular medicine. Indexed in PubMed, Scopus, and Web of Science.
- 1 January 2025
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 30 (4) , 276
Open AccessReply to Letter to the Editor: “Methodological Considerations in Non-Sustained Atrial Fibrillation and Stroke Risk”
The Anatolian Journal of Cardiology - Peer-reviewed cardiology journal publishing original research, reviews, case reports. Impact Factor 1.5. The Anatolian Journal of Cardiology - Leading international cardiology journal with Impact Factor 1.5. Publishing original research, reviews, and case reports in cardiovascular medicine. Indexed in PubMed, Scopus, and Web of Science.
- Open Access
- 1 January 2025
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 30 (3) , 202-203
Reply to Letter to the Editor: “Comments on Nonsustained Atrial Fibrillation and Stroke Risk: Methodological and Interpretive Considerations”
- 1 January 2025
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 30 (3) , 202-203
Open AccessReply to Letter to the Editor: “Comments on Nonsustained Atrial Fibrillation and Stroke Risk: Methodological and Interpretive Considerations”
- Open Access
- 1 January 2025
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 38 (suppl_1) , 401-408
12. Nonsustained Atrial Fibrillation in Ambulatory ECG Recording and Thromboembolic Events in Long term Follow-Up
Background: Short-lasting (<30 s), nonsustained episodes of atrial fibrillation (NS-AF) are frequently observed in ambulatory ECG monitoring. Although they a
- 1 January 2025
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 38 (suppl_1) , 401-408
Open Access12. Nonsustained Atrial Fibrillation in Ambulatory ECG Recording and Thromboembolic Events in Long term Follow-Up
Background: Short-lasting (<30 s), nonsustained episodes of atrial fibrillation (NS-AF) are frequently observed in ambulatory ECG monitoring. Although they a
- Open Access
- 1 July 2023
- Published by Galenos Yayinevi in Turkish Journal of Thoracic and Cardiovascular Surgery
- Vol. 31 (3) , 388-397
Results of surgical treatment of pulmonary artery sarcomas: Does histology affect survival?
Background: In this study, we aimed to describe our experience with primary pulmonary artery sarcoma in patients who underwent pulmonary endarterectomy and to evaluate clinical features, treatment, outcomes, and survival rates according to the histological subtypes of this malignant disease. Methods: Between March 2011 and May 2022, a total of 13 patients (7 males, 6 females; mean age: 52.6±13.0 years; range, 30 to 69 years) who underwent pulmonary endarterectomy and diagnosed with a pulmonary artery sarcoma were retrospectively analyzed. The diagnosis was confirmed histopathologically in all patients. Data including demographics, clinical characteristics, intra- and postoperative complications, length of hospital stay, morbidity, mortality, and short-term and long-term outcomes were recorded. Operative mortality was defined as death in the hospital or within 30 days of surgery. Results: Mortality was observed in one patient due to massive hemoptysis. Morbidity developed in two patients due to acute respiratory distress. Pulmonary vascular resistance improved significantly from 508 dyn/s/cm -5 to 191 dyn/s/cm -5 (p Conclusion: Pulmonary artery sarcoma may mimic chronic thromboembolic pulmonary hypertension. Patients with a suspected diagnosis of pulmonary artery sarcoma should be referred to expert pulmonary endarterectomy centers for surgery where a multidisciplinary team is available. Pulmonary endarterectomy has both diagnostic and therapeutic value and may improve survival and quality of life. Patients with intimal sarcoma have longer survival compared to those with leiomyosarcoma.
- 1 July 2023
- Published by Galenos Yayinevi in Turkish Journal of Thoracic and Cardiovascular Surgery
- Vol. 31 (3) , 388-397
Open AccessResults of surgical treatment of pulmonary artery sarcomas: Does histology affect survival?
Background: In this study, we aimed to describe our experience with primary pulmonary artery sarcoma in patients who underwent pulmonary endarterectomy and to evaluate clinical features, treatment, outcomes, and survival rates according to the histological subtypes of this malignant disease. Methods: Between March 2011 and May 2022, a total of 13 patients (7 males, 6 females; mean age: 52.6±13.0 years; range, 30 to 69 years) who underwent pulmonary endarterectomy and diagnosed with a pulmonary artery sarcoma were retrospectively analyzed. The diagnosis was confirmed histopathologically in all patients. Data including demographics, clinical characteristics, intra- and postoperative complications, length of hospital stay, morbidity, mortality, and short-term and long-term outcomes were recorded. Operative mortality was defined as death in the hospital or within 30 days of surgery. Results: Mortality was observed in one patient due to massive hemoptysis. Morbidity developed in two patients due to acute respiratory distress. Pulmonary vascular resistance improved significantly from 508 dyn/s/cm -5 to 191 dyn/s/cm -5 (p Conclusion: Pulmonary artery sarcoma may mimic chronic thromboembolic pulmonary hypertension. Patients with a suspected diagnosis of pulmonary artery sarcoma should be referred to expert pulmonary endarterectomy centers for surgery where a multidisciplinary team is available. Pulmonary endarterectomy has both diagnostic and therapeutic value and may improve survival and quality of life. Patients with intimal sarcoma have longer survival compared to those with leiomyosarcoma.
- 8 October 2022
- Published by Elsevier in Heart & Lung
- Vol. 57, 173-179
Evaluation of primary and accessory respiratory muscles and their influence on exercise capacity and dyspnea in pulmonary arterial hypertension
- 8 October 2022
- Published by Elsevier in Heart & Lung
- Vol. 57, 173-179
Evaluation of primary and accessory respiratory muscles and their influence on exercise capacity and dyspnea in pulmonary arterial hypertension